Recent studies indicate that acidic nanoparticles may enhance lysosomal degradation by decreasing lysosomal pH, thereby restoring lysosomal function in various PD models, including those with ATP13A2 and GBA mutations[89]. This evidence concerns the gene ATP13A2 and Parkinson disease.